Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€528.00
20.04.20
20.04.20
€290.00
23.08.20
23.08.20
-1.52%
23.08.20
23.08.20
Abbott Laboratories
Start price
Target price
Perf. (%)
€86.80
20.04.20
20.04.20
€120.00
04.11.21
04.11.21
28.11%
04.11.21
04.11.21
McDonalds Corp.
Start price
Target price
Perf. (%)
€171.80
20.04.20
20.04.20
€190.00
02.05.20
02.05.20
-3.38%
02.05.20
02.05.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
20.04.20
20.04.20
€85.00
02.05.20
02.05.20
-1.54%
02.05.20
02.05.20
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€534.90
20.04.20
20.04.20
-
25.05.20
25.05.20
-2.39%
25.05.20
25.05.20
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€534.90
20.04.20
20.04.20
-
01.05.20
01.05.20
-9.33%
01.05.20
01.05.20
Nextera Energy Inc.
Start price
Target price
Perf. (%)
€56.25
19.04.20
19.04.20
€62.50
04.05.20
04.05.20
-6.29%
04.05.20
04.05.20
Differentiated customer and product portfolio
Growths faster than the competition
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Nextera Energy Inc.
Start price
Target price
Perf. (%)
€56.25
19.04.20
19.04.20
€76.00
04.11.21
04.11.21
29.88%
05.11.21
05.11.21
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€162.65
19.04.20
19.04.20
€293.33
04.11.21
04.11.21
96.37%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Microsoft Corp.
Start price
Target price
Perf. (%)
€164.92
19.04.20
19.04.20
€180.00
25.06.20
25.06.20
5.80%
25.06.20
25.06.20
Risky Investment
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€51.89
19.04.20
19.04.20
-
14.05.20
14.05.20
-5.16%
14.05.20
14.05.20
Oracle Corp.
Start price
Target price
Perf. (%)
€49.97
18.04.20
18.04.20
€55.00
04.05.20
04.05.20
-5.16%
04.05.20
04.05.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Adobe Inc.
Start price
Target price
Perf. (%)
€316.00
18.04.20
18.04.20
€475.00
15.10.20
15.10.20
35.54%
15.10.20
15.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Berkshire Hathaway Inc. B
Start price
Target price
Perf. (%)
€176.72
18.04.20
18.04.20
-
19.05.20
19.05.20
-9.29%
19.05.20
19.05.20